Patent ductus arteriosus (PDA) remains a prominent clinical challenge in the management of preterm infants. During fetal life, the ductus arteriosus diverts blood away from the underdeveloped ...

Active treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants within the first 2 weeks of life was associated with worse outcomes than expectant management.

In summary, preterm infants with poor early ductal constriction can have important early hemodynamic consequences on both the systemic and pulmonary circulation as a result of left-to-right shunts.

How Do Patients Present With PDA? Preterm infants, older children, and adults with PDA all may present with the classic features described above.

While medications can close the PDA in about two-thirds of premature infants, the remaining third, as well as those requiring urgent closure, will still need a procedural intervention.

Poster: “Impact of Transcatheter Patent Ductus Arteriosus Closure on the Incidence of Pulmonary Vein Stenosis in Premature Infants” 9:15 – 10:15 a.m.; Abstract #3412, Poster area 3, Board #3115 ...

Merit Medical Systems initiates a study to evaluate the Bloom Micro Occluder System for treating patent ductus arteriosus in premature infants.

Published in Journal of the Society for Cardiovascular Angiography & Interventions, "SCAI Position Statement on Transcatheter Occlusion of Patent Ductus Arteriosus in Premature Infants" offers a ...

SCAI releases new guidance to improve safety and outcomes of patent ductus arteriosus (PDA) closure in premature infants Position statement provides best-practice guidance for treatment of PDA ...

Once a PDA is suspected or confirmed, the 2 main questions are (1) how to treat and (2) when to treat a particular infant This clinical controversy recently was the subject of an excellent ...